nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR2C—endogenous depression	0.264	0.328	CbGaD
Atomoxetine—SLC6A4—endogenous depression	0.219	0.272	CbGaD
Atomoxetine—HTR2A—endogenous depression	0.168	0.209	CbGaD
Atomoxetine—CYP2D6—endogenous depression	0.154	0.191	CbGaD
Atomoxetine—SLC6A2—locus ceruleus—endogenous depression	0.00634	0.0797	CbGeAlD
Atomoxetine—SLC6A2—sympathetic nervous system—endogenous depression	0.00501	0.063	CbGeAlD
Atomoxetine—HTR2A—locus ceruleus—endogenous depression	0.00381	0.0479	CbGeAlD
Atomoxetine—SLC6A2—autonomic nervous system—endogenous depression	0.00337	0.0424	CbGeAlD
Atomoxetine—HTR2A—sympathetic nervous system—endogenous depression	0.00301	0.0379	CbGeAlD
Atomoxetine—HTR2A—vagus nerve—endogenous depression	0.00292	0.0367	CbGeAlD
Atomoxetine—NPY1R—forebrain—endogenous depression	0.00231	0.0291	CbGeAlD
Atomoxetine—NPY1R—adrenal cortex—endogenous depression	0.00214	0.027	CbGeAlD
Atomoxetine—HTR2A—autonomic nervous system—endogenous depression	0.00203	0.0255	CbGeAlD
Atomoxetine—NPY1R—pituitary gland—endogenous depression	0.00173	0.0218	CbGeAlD
Atomoxetine—HTR6—forebrain—endogenous depression	0.00163	0.0205	CbGeAlD
Atomoxetine—HTR2A—pineal body—endogenous depression	0.00157	0.0197	CbGeAlD
Atomoxetine—NPY1R—adrenal gland—endogenous depression	0.00155	0.0195	CbGeAlD
Atomoxetine—NPY1R—thyroid gland—endogenous depression	0.00149	0.0188	CbGeAlD
Atomoxetine—NPY1R—endocrine gland—endogenous depression	0.00134	0.0169	CbGeAlD
Atomoxetine—NPY1R—nervous system—endogenous depression	0.00126	0.0158	CbGeAlD
Atomoxetine—NPY1R—central nervous system—endogenous depression	0.00121	0.0152	CbGeAlD
Atomoxetine—HTR1B—brainstem—endogenous depression	0.00102	0.0128	CbGeAlD
Atomoxetine—SLC6A3—brainstem—endogenous depression	0.00101	0.0127	CbGeAlD
Atomoxetine—HTR1D—brainstem—endogenous depression	0.000985	0.0124	CbGeAlD
Atomoxetine—HTR1B—forebrain—endogenous depression	0.000982	0.0123	CbGeAlD
Atomoxetine—HTR2C—brainstem—endogenous depression	0.000975	0.0123	CbGeAlD
Atomoxetine—SLC6A3—forebrain—endogenous depression	0.000974	0.0122	CbGeAlD
Atomoxetine—NPY1R—brain—endogenous depression	0.00096	0.0121	CbGeAlD
Atomoxetine—HTR1D—forebrain—endogenous depression	0.000951	0.0119	CbGeAlD
Atomoxetine—HTR2C—forebrain—endogenous depression	0.000941	0.0118	CbGeAlD
Atomoxetine—SLC6A4—brainstem—endogenous depression	0.000925	0.0116	CbGeAlD
Atomoxetine—SLC6A4—forebrain—endogenous depression	0.000892	0.0112	CbGeAlD
Atomoxetine—HTR6—nervous system—endogenous depression	0.000884	0.0111	CbGeAlD
Atomoxetine—HTR6—central nervous system—endogenous depression	0.000851	0.0107	CbGeAlD
Atomoxetine—HTR1B—cardiovascular system—endogenous depression	0.00083	0.0104	CbGeAlD
Atomoxetine—SLC6A2—brainstem—endogenous depression	0.000814	0.0102	CbGeAlD
Atomoxetine—HTR1D—cardiovascular system—endogenous depression	0.000804	0.0101	CbGeAlD
Atomoxetine—SLC6A2—forebrain—endogenous depression	0.000786	0.00987	CbGeAlD
Atomoxetine—HTR6—brain—endogenous depression	0.000676	0.0085	CbGeAlD
Atomoxetine—HTR1B—midbrain—endogenous depression	0.000648	0.00815	CbGeAlD
Atomoxetine—SLC6A3—midbrain—endogenous depression	0.000643	0.00808	CbGeAlD
Atomoxetine—HTR1D—midbrain—endogenous depression	0.000628	0.00789	CbGeAlD
Atomoxetine—HTR2C—midbrain—endogenous depression	0.000622	0.00781	CbGeAlD
Atomoxetine—SLC6A4—midbrain—endogenous depression	0.000589	0.00741	CbGeAlD
Atomoxetine—HTR1B—endocrine gland—endogenous depression	0.000569	0.00716	CbGeAlD
Atomoxetine—HTR1B—nervous system—endogenous depression	0.000533	0.0067	CbGeAlD
Atomoxetine—SLC6A3—nervous system—endogenous depression	0.000529	0.00664	CbGeAlD
Atomoxetine—SLC6A2—adrenal gland—endogenous depression	0.000525	0.0066	CbGeAlD
Atomoxetine—SLC6A4—endocrine gland—endogenous depression	0.000518	0.00651	CbGeAlD
Atomoxetine—HTR1D—nervous system—endogenous depression	0.000516	0.00649	CbGeAlD
Atomoxetine—HTR1B—central nervous system—endogenous depression	0.000513	0.00645	CbGeAlD
Atomoxetine—HTR2C—nervous system—endogenous depression	0.000511	0.00642	CbGeAlD
Atomoxetine—SLC6A3—central nervous system—endogenous depression	0.000509	0.0064	CbGeAlD
Atomoxetine—SLC6A3—cerebellum—endogenous depression	0.000497	0.00625	CbGeAlD
Atomoxetine—HTR1D—central nervous system—endogenous depression	0.000497	0.00624	CbGeAlD
Atomoxetine—HTR2C—central nervous system—endogenous depression	0.000492	0.00618	CbGeAlD
Atomoxetine—HTR2A—brainstem—endogenous depression	0.000489	0.00615	CbGeAlD
Atomoxetine—SLC6A4—nervous system—endogenous depression	0.000484	0.00609	CbGeAlD
Atomoxetine—HTR2A—forebrain—endogenous depression	0.000472	0.00593	CbGeAlD
Atomoxetine—SLC6A4—central nervous system—endogenous depression	0.000466	0.00586	CbGeAlD
Atomoxetine—SLC6A2—endocrine gland—endogenous depression	0.000456	0.00573	CbGeAlD
Atomoxetine—CYP2D6—brainstem—endogenous depression	0.000446	0.0056	CbGeAlD
Atomoxetine—CYP2D6—forebrain—endogenous depression	0.00043	0.00541	CbGeAlD
Atomoxetine—CYP2C19—endocrine gland—endogenous depression	0.000429	0.00539	CbGeAlD
Atomoxetine—SLC6A2—nervous system—endogenous depression	0.000426	0.00536	CbGeAlD
Atomoxetine—Reboxetine—HTR2C—endogenous depression	0.000424	0.0621	CrCbGaD
Atomoxetine—SLC6A2—central nervous system—endogenous depression	0.000411	0.00516	CbGeAlD
Atomoxetine—HTR1B—brain—endogenous depression	0.000407	0.00512	CbGeAlD
Atomoxetine—SLC6A3—brain—endogenous depression	0.000404	0.00508	CbGeAlD
Atomoxetine—HTR2A—cardiovascular system—endogenous depression	0.000399	0.00502	CbGeAlD
Atomoxetine—HTR1D—brain—endogenous depression	0.000394	0.00496	CbGeAlD
Atomoxetine—HTR2C—brain—endogenous depression	0.000391	0.00491	CbGeAlD
Atomoxetine—SLC6A4—brain—endogenous depression	0.00037	0.00465	CbGeAlD
Atomoxetine—HTR2A—pituitary gland—endogenous depression	0.000354	0.00444	CbGeAlD
Atomoxetine—Reboxetine—SLC6A4—endogenous depression	0.000351	0.0515	CrCbGaD
Atomoxetine—Duloxetine—HTR2C—endogenous depression	0.000326	0.0478	CrCbGaD
Atomoxetine—SLC6A2—brain—endogenous depression	0.000326	0.0041	CbGeAlD
Atomoxetine—Protriptyline—SLC6A4—endogenous depression	0.000323	0.0473	CrCbGaD
Atomoxetine—HTR2A—adrenal gland—endogenous depression	0.000316	0.00397	CbGeAlD
Atomoxetine—Maprotiline—HTR7—endogenous depression	0.000315	0.0461	CrCbGaD
Atomoxetine—HTR2A—midbrain—endogenous depression	0.000312	0.00392	CbGeAlD
Atomoxetine—Pseudoephedrine—MAOA—endogenous depression	0.000297	0.0435	CrCbGaD
Atomoxetine—HTR2A—endocrine gland—endogenous depression	0.000274	0.00344	CbGeAlD
Atomoxetine—Duloxetine—SLC6A4—endogenous depression	0.00027	0.0396	CrCbGaD
Atomoxetine—Fluoxetine—HTR2C—endogenous depression	0.000266	0.0389	CrCbGaD
Atomoxetine—HTR2A—nervous system—endogenous depression	0.000256	0.00322	CbGeAlD
Atomoxetine—CYP3A4—endocrine gland—endogenous depression	0.000254	0.00319	CbGeAlD
Atomoxetine—CYP2D6—endocrine gland—endogenous depression	0.000249	0.00314	CbGeAlD
Atomoxetine—Maprotiline—HTR2C—endogenous depression	0.000248	0.0364	CrCbGaD
Atomoxetine—Reboxetine—CYP2D6—endogenous depression	0.000247	0.0362	CrCbGaD
Atomoxetine—HTR2A—central nervous system—endogenous depression	0.000247	0.0031	CbGeAlD
Atomoxetine—HTR2A—cerebellum—endogenous depression	0.000241	0.00303	CbGeAlD
Atomoxetine—CYP3A4—nervous system—endogenous depression	0.000237	0.00298	CbGeAlD
Atomoxetine—CYP2D6—nervous system—endogenous depression	0.000234	0.00294	CbGeAlD
Atomoxetine—CYP3A4—central nervous system—endogenous depression	0.000228	0.00287	CbGeAlD
Atomoxetine—Protriptyline—CYP2D6—endogenous depression	0.000227	0.0332	CrCbGaD
Atomoxetine—CYP2D6—central nervous system—endogenous depression	0.000225	0.00283	CbGeAlD
Atomoxetine—Fluoxetine—SLC6A4—endogenous depression	0.00022	0.0323	CrCbGaD
Atomoxetine—CYP2D6—cerebellum—endogenous depression	0.00022	0.00276	CbGeAlD
Atomoxetine—Duloxetine—HTR2A—endogenous depression	0.000208	0.0304	CrCbGaD
Atomoxetine—HTR2A—brain—endogenous depression	0.000196	0.00246	CbGeAlD
Atomoxetine—Pseudoephedrine—SLC6A4—endogenous depression	0.000191	0.028	CrCbGaD
Atomoxetine—Duloxetine—CYP2D6—endogenous depression	0.00019	0.0278	CrCbGaD
Atomoxetine—CYP2D6—brain—endogenous depression	0.000178	0.00224	CbGeAlD
Atomoxetine—Fluoxetine—HTR2A—endogenous depression	0.000169	0.0248	CrCbGaD
Atomoxetine—Tolterodine—CYP2D6—endogenous depression	0.000162	0.0238	CrCbGaD
Atomoxetine—Maprotiline—HTR2A—endogenous depression	0.000158	0.0232	CrCbGaD
Atomoxetine—Propranolol—HTR1A—endogenous depression	0.000158	0.0231	CrCbGaD
Atomoxetine—Benzatropine—CYP2D6—endogenous depression	0.000156	0.0229	CrCbGaD
Atomoxetine—Fluoxetine—CYP2D6—endogenous depression	0.000155	0.0227	CrCbGaD
Atomoxetine—Nortriptyline—HTR2C—endogenous depression	0.000149	0.0219	CrCbGaD
Atomoxetine—Nortriptyline—HTR1A—endogenous depression	0.000145	0.0212	CrCbGaD
Atomoxetine—Maprotiline—CYP2D6—endogenous depression	0.000145	0.0212	CrCbGaD
Atomoxetine—Propafenone—CYP2D6—endogenous depression	0.000138	0.0202	CrCbGaD
Atomoxetine—Pseudoephedrine—CYP2D6—endogenous depression	0.000134	0.0197	CrCbGaD
Atomoxetine—Nortriptyline—SLC6A4—endogenous depression	0.000124	0.0181	CrCbGaD
Atomoxetine—Desipramine—HTR2C—endogenous depression	0.000123	0.018	CrCbGaD
Atomoxetine—Desipramine—HTR1A—endogenous depression	0.000119	0.0175	CrCbGaD
Atomoxetine—NPY1R—Signaling Pathways—ADM—endogenous depression	0.000107	0.000991	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—OXT—endogenous depression	0.000106	0.000982	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CRH—endogenous depression	0.000106	0.000982	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000106	0.000977	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HTR1A—endogenous depression	0.000105	0.000973	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HTR1A—endogenous depression	0.000105	0.000965	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000103	0.000955	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000103	0.000954	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—HTR1A—endogenous depression	0.000102	0.000945	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000102	0.000941	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HTR2C—endogenous depression	0.000102	0.00094	CbGpPWpGaD
Atomoxetine—Desipramine—SLC6A4—endogenous depression	0.000102	0.0149	CrCbGaD
Atomoxetine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000101	0.000934	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HTR2C—endogenous depression	0.000101	0.000932	CbGpPWpGaD
Atomoxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000101	0.000929	CbGpPWpGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000101	0.000929	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	9.98e-05	0.000921	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—HTR2C—endogenous depression	9.9e-05	0.000913	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—ADM—endogenous depression	9.63e-05	0.000888	CbGpPWpGaD
Atomoxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	9.58e-05	0.000883	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—NR3C1—endogenous depression	9.58e-05	0.000883	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—HTR2A—endogenous depression	9.57e-05	0.000883	CbGpPWpGaD
Atomoxetine—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	9.5e-05	0.000877	CbGpPWpGaD
Atomoxetine—Nortriptyline—HTR2A—endogenous depression	9.5e-05	0.0139	CrCbGaD
Atomoxetine—Propranolol—CYP2D6—endogenous depression	9.45e-05	0.0138	CrCbGaD
Atomoxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	9.31e-05	0.000859	CbGpPWpGaD
Atomoxetine—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	9.31e-05	0.000858	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	9.2e-05	0.000849	CbGpPWpGaD
Atomoxetine—HTR2C—G alpha (q) signalling events—HTR2A—endogenous depression	9.12e-05	0.000842	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CRH—endogenous depression	9e-05	0.000831	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—OXT—endogenous depression	9e-05	0.000831	CbGpPWpGaD
Atomoxetine—SLC6A3—Neuronal System—COMT—endogenous depression	8.99e-05	0.00083	CbGpPWpGaD
Atomoxetine—SLC6A3—Neuronal System—MAOA—endogenous depression	8.93e-05	0.000824	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HTR7—endogenous depression	8.92e-05	0.000823	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	8.9e-05	0.000821	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	8.86e-05	0.000817	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HTR7—endogenous depression	8.85e-05	0.000817	CbGpPWpGaD
Atomoxetine—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	8.78e-05	0.00081	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	8.74e-05	0.000807	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—HTR2A—endogenous depression	8.69e-05	0.000802	CbGpPWpGaD
Atomoxetine—Nortriptyline—CYP2D6—endogenous depression	8.69e-05	0.0127	CrCbGaD
Atomoxetine—HTR1B—GPCR ligand binding—HTR7—endogenous depression	8.67e-05	0.0008	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR1A—endogenous depression	8.67e-05	0.0008	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	8.63e-05	0.000796	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	8.55e-05	0.000789	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR2C—endogenous depression	8.37e-05	0.000772	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—ADM—endogenous depression	8.36e-05	0.000771	CbGpPWpGaD
Atomoxetine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	8.21e-05	0.000757	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	8.2e-05	0.000757	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—POMC—endogenous depression	8.18e-05	0.000754	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	8.16e-05	0.000753	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	8.14e-05	0.000751	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CRH—endogenous depression	8.07e-05	0.000744	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—OXT—endogenous depression	8.07e-05	0.000744	CbGpPWpGaD
Atomoxetine—Diphenhydramine—CYP2D6—endogenous depression	8.03e-05	0.0118	CrCbGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—POMC—endogenous depression	8.01e-05	0.000739	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	7.97e-05	0.000735	CbGpPWpGaD
Atomoxetine—Desipramine—HTR2A—endogenous depression	7.82e-05	0.0115	CrCbGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR1A—endogenous depression	7.77e-05	0.000716	CbGpPWpGaD
Atomoxetine—Methadone—CYP2D6—endogenous depression	7.76e-05	0.0114	CrCbGaD
Atomoxetine—NPY1R—GPCR downstream signaling—POMC—endogenous depression	7.64e-05	0.000705	CbGpPWpGaD
Atomoxetine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	7.58e-05	0.000699	CbGpPWpGaD
Atomoxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.55e-05	0.000696	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	7.49e-05	0.000691	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—ADM—endogenous depression	7.39e-05	0.000682	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—ADM—endogenous depression	7.33e-05	0.000676	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR7—endogenous depression	7.33e-05	0.000676	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—ADM—endogenous depression	7.18e-05	0.000662	CbGpPWpGaD
Atomoxetine—Desipramine—CYP2D6—endogenous depression	7.15e-05	0.0105	CrCbGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	7.05e-05	0.000651	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CRH—endogenous depression	7.01e-05	0.000646	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—OXT—endogenous depression	7.01e-05	0.000646	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—POMC—endogenous depression	6.94e-05	0.00064	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—COMT—endogenous depression	6.75e-05	0.000622	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HTR1A—endogenous depression	6.74e-05	0.000622	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—ADM—endogenous depression	6.71e-05	0.000619	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—MAOA—endogenous depression	6.7e-05	0.000618	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—ADM—endogenous depression	6.66e-05	0.000614	CbGpPWpGaD
Atomoxetine—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	6.65e-05	0.000614	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR7—endogenous depression	6.57e-05	0.000606	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	6.55e-05	0.000604	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—ADM—endogenous depression	6.52e-05	0.000601	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HTR2C—endogenous depression	6.51e-05	0.000601	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	6.5e-05	0.0006	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	6.37e-05	0.000587	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HTR2A—endogenous depression	6.25e-05	0.000576	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—COMT—endogenous depression	6.2e-05	0.000572	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HTR2A—endogenous depression	6.2e-05	0.000572	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—OXT—endogenous depression	6.19e-05	0.000571	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CRH—endogenous depression	6.19e-05	0.000571	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—MAOA—endogenous depression	6.16e-05	0.000568	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CRH—endogenous depression	6.14e-05	0.000567	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—OXT—endogenous depression	6.14e-05	0.000567	CbGpPWpGaD
Atomoxetine—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	6.12e-05	0.000564	CbGpPWpGaD
Atomoxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	6.09e-05	0.000562	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—HTR2A—endogenous depression	6.07e-05	0.00056	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	6.04e-05	0.000557	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—OXT—endogenous depression	6.02e-05	0.000555	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CRH—endogenous depression	6.02e-05	0.000555	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR1A—endogenous depression	5.96e-05	0.00055	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR1A—endogenous depression	5.91e-05	0.000546	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR1A—endogenous depression	5.79e-05	0.000534	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR2C—endogenous depression	5.76e-05	0.000531	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR2C—endogenous depression	5.71e-05	0.000527	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HTR7—endogenous depression	5.7e-05	0.000526	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CRH—endogenous depression	5.62e-05	0.000519	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—OXT—endogenous depression	5.62e-05	0.000519	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR2C—endogenous depression	5.59e-05	0.000516	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CRH—endogenous depression	5.58e-05	0.000515	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—OXT—endogenous depression	5.58e-05	0.000515	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—OXT—endogenous depression	5.46e-05	0.000504	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CRH—endogenous depression	5.46e-05	0.000504	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—ADM—endogenous depression	5.44e-05	0.000502	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR1A—endogenous depression	5.41e-05	0.000499	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR1A—endogenous depression	5.37e-05	0.000495	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	5.35e-05	0.000494	CbGpPWpGaD
Atomoxetine—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	5.28e-05	0.000487	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR1A—endogenous depression	5.26e-05	0.000485	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR2C—endogenous depression	5.23e-05	0.000482	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR2C—endogenous depression	5.19e-05	0.000479	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR2A—endogenous depression	5.13e-05	0.000474	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR2C—endogenous depression	5.08e-05	0.000469	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR7—endogenous depression	5.04e-05	0.000465	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR7—endogenous depression	5e-05	0.000462	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—POMC—endogenous depression	4.99e-05	0.00046	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—POMC—endogenous depression	4.95e-05	0.000457	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—ADM—endogenous depression	4.94e-05	0.000456	CbGpPWpGaD
Atomoxetine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	4.94e-05	0.000455	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR7—endogenous depression	4.9e-05	0.000452	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—POMC—endogenous depression	4.85e-05	0.000447	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	4.83e-05	0.000445	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—ADM—endogenous depression	4.72e-05	0.000436	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR2A—endogenous depression	4.6e-05	0.000424	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR7—endogenous depression	4.58e-05	0.000422	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CRH—endogenous depression	4.56e-05	0.000421	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—OXT—endogenous depression	4.56e-05	0.000421	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR7—endogenous depression	4.54e-05	0.000419	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR7—endogenous depression	4.45e-05	0.00041	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR1A—endogenous depression	4.39e-05	0.000405	CbGpPWpGaD
Atomoxetine—CYP2C19—Biological oxidations—POMC—endogenous depression	4.36e-05	0.000402	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—WASF2—endogenous depression	4.33e-05	0.0004	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—WASF2—endogenous depression	4.3e-05	0.000397	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—ADM—endogenous depression	4.29e-05	0.000396	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—WASF2—endogenous depression	4.21e-05	0.000388	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	4.19e-05	0.000387	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—WASF1—endogenous depression	4.15e-05	0.000383	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CRH—endogenous depression	4.14e-05	0.000382	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—OXT—endogenous depression	4.14e-05	0.000382	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—WASF1—endogenous depression	4.12e-05	0.00038	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—POMC—endogenous depression	4.1e-05	0.000378	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—COMT—endogenous depression	4.06e-05	0.000374	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—WASF1—endogenous depression	4.04e-05	0.000372	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—MAOA—endogenous depression	4.03e-05	0.000372	CbGpPWpGaD
Atomoxetine—CYP2D6—Biological oxidations—POMC—endogenous depression	4.01e-05	0.00037	CbGpPWpGaD
Atomoxetine—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	4e-05	0.000369	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR1A—endogenous depression	3.99e-05	0.000368	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ADM—endogenous depression	3.96e-05	0.000366	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CRH—endogenous depression	3.96e-05	0.000365	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—OXT—endogenous depression	3.96e-05	0.000365	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ADM—endogenous depression	3.93e-05	0.000363	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ADM—endogenous depression	3.85e-05	0.000355	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR1A—endogenous depression	3.81e-05	0.000352	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR7—endogenous depression	3.71e-05	0.000342	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR2C—endogenous depression	3.68e-05	0.00034	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—POMC—endogenous depression	3.67e-05	0.000339	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CRH—endogenous depression	3.6e-05	0.000332	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—OXT—endogenous depression	3.6e-05	0.000332	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR2A—endogenous depression	3.53e-05	0.000326	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR2A—endogenous depression	3.5e-05	0.000323	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR1A—endogenous depression	3.46e-05	0.000319	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR2A—endogenous depression	3.43e-05	0.000317	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR7—endogenous depression	3.37e-05	0.000311	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR2C—endogenous depression	3.34e-05	0.000308	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—OXT—endogenous depression	3.32e-05	0.000306	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CRH—endogenous depression	3.32e-05	0.000306	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CRH—endogenous depression	3.3e-05	0.000304	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—OXT—endogenous depression	3.3e-05	0.000304	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CRH—endogenous depression	3.23e-05	0.000298	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—OXT—endogenous depression	3.23e-05	0.000298	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR7—endogenous depression	3.22e-05	0.000297	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR2A—endogenous depression	3.21e-05	0.000296	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR1A—endogenous depression	3.2e-05	0.000295	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—WASF2—endogenous depression	3.19e-05	0.000294	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—POMC—endogenous depression	3.19e-05	0.000294	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR2A—endogenous depression	3.18e-05	0.000294	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR1A—endogenous depression	3.17e-05	0.000293	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR2A—endogenous depression	3.12e-05	0.000287	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR1A—endogenous depression	3.11e-05	0.000287	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2C—endogenous depression	3.09e-05	0.000285	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2C—endogenous depression	3.06e-05	0.000283	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—WASF1—endogenous depression	3.06e-05	0.000282	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2C—endogenous depression	3e-05	0.000277	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR7—endogenous depression	2.93e-05	0.00027	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ADM—endogenous depression	2.92e-05	0.000269	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—POMC—endogenous depression	2.82e-05	0.00026	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—POMC—endogenous depression	2.8e-05	0.000258	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—WASF2—endogenous depression	2.77e-05	0.000256	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—POMC—endogenous depression	2.74e-05	0.000253	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR7—endogenous depression	2.7e-05	0.000249	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR7—endogenous depression	2.68e-05	0.000248	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—WASF1—endogenous depression	2.66e-05	0.000245	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR7—endogenous depression	2.63e-05	0.000242	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—POMC—endogenous depression	2.62e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR2A—endogenous depression	2.6e-05	0.00024	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—POMC—endogenous depression	2.56e-05	0.000236	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—POMC—endogenous depression	2.54e-05	0.000234	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ADM—endogenous depression	2.53e-05	0.000234	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—TPH1—endogenous depression	2.51e-05	0.000232	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—POMC—endogenous depression	2.49e-05	0.00023	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CRH—endogenous depression	2.45e-05	0.000226	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—OXT—endogenous depression	2.45e-05	0.000226	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR2A—endogenous depression	2.36e-05	0.000218	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR1A—endogenous depression	2.35e-05	0.000217	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—TPH1—endogenous depression	2.31e-05	0.000213	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CRH—endogenous depression	2.12e-05	0.000196	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—OXT—endogenous depression	2.12e-05	0.000196	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—POMC—endogenous depression	2.08e-05	0.000192	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR1A—endogenous depression	2.04e-05	0.000189	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR7—endogenous depression	1.99e-05	0.000184	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR2C—endogenous depression	1.97e-05	0.000182	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—TPH2—endogenous depression	1.9e-05	0.000176	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CACNB2—endogenous depression	1.9e-05	0.000176	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2A—endogenous depression	1.89e-05	0.000175	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—POMC—endogenous depression	1.89e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2A—endogenous depression	1.88e-05	0.000173	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—DPYD—endogenous depression	1.87e-05	0.000173	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2A—endogenous depression	1.84e-05	0.00017	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—POMC—endogenous depression	1.8e-05	0.000166	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—TPH2—endogenous depression	1.75e-05	0.000162	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CACNB2—endogenous depression	1.75e-05	0.000162	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CACNA1C—endogenous depression	1.74e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR7—endogenous depression	1.73e-05	0.00016	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—DPYD—endogenous depression	1.72e-05	0.000159	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	1.67e-05	0.000154	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—POMC—endogenous depression	1.64e-05	0.000151	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CACNA1C—endogenous depression	1.6e-05	0.000148	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CYP2D6—endogenous depression	1.52e-05	0.00014	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—POMC—endogenous depression	1.51e-05	0.00014	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—TPH1—endogenous depression	1.51e-05	0.000139	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—POMC—endogenous depression	1.5e-05	0.000138	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—POMC—endogenous depression	1.47e-05	0.000136	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR2A—endogenous depression	1.39e-05	0.000129	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—COMT—endogenous depression	1.15e-05	0.000106	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MAOA—endogenous depression	1.15e-05	0.000106	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—TPH2—endogenous depression	1.14e-05	0.000106	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CACNB2—endogenous depression	1.14e-05	0.000106	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—DPYD—endogenous depression	1.13e-05	0.000104	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—POMC—endogenous depression	1.11e-05	0.000103	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—COMT—endogenous depression	1.06e-05	9.79e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MAOA—endogenous depression	1.05e-05	9.72e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.05e-05	9.66e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—POMC—endogenous depression	9.67e-06	8.92e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYP2D6—endogenous depression	9.15e-06	8.44e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—POMC—endogenous depression	7.46e-06	6.88e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—COMT—endogenous depression	6.94e-06	6.4e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MAOA—endogenous depression	6.89e-06	6.35e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—POMC—endogenous depression	6.86e-06	6.33e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—POMC—endogenous depression	4.48e-06	4.14e-05	CbGpPWpGaD
